Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2141 | 2343 | 41.1 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
478 | 3 | PHAGE DISPLAY//CELL FREE PROTEIN SYNTHESIS//ANTIBODY ENGINEERING | 23687 |
1834 | 2 | PHAGE DISPLAY//ANTIBODY ENGINEERING//BISPECIFIC ANTIBODY | 6173 |
2141 | 1 | PHAGE DISPLAY//SCFV//ANTIBODY LIBRARY | 2343 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | authKW | 1035658 | 20% | 17% | 461 |
2 | SCFV | authKW | 818801 | 9% | 30% | 212 |
3 | ANTIBODY LIBRARY | authKW | 627160 | 3% | 63% | 76 |
4 | SINGLE CHAIN FV | authKW | 552425 | 5% | 40% | 107 |
5 | ANTIBODY ENGINEERING | authKW | 468366 | 6% | 28% | 130 |
6 | INTRABODY | authKW | 446438 | 3% | 49% | 70 |
7 | RECOMBINANT ANTIBODY | authKW | 233380 | 4% | 20% | 89 |
8 | PHAGE ANTIBODY | authKW | 226214 | 1% | 69% | 25 |
9 | INTRACELLULAR ANTIBODIES | authKW | 192436 | 1% | 62% | 24 |
10 | SINGLE CHAIN ANTIBODY | authKW | 169471 | 3% | 21% | 63 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemical Research Methods | 12254 | 24% | 0% | 574 |
2 | Biotechnology & Applied Microbiology | 7072 | 24% | 0% | 563 |
3 | Biochemistry & Molecular Biology | 5433 | 41% | 0% | 967 |
4 | Immunology | 5053 | 23% | 0% | 547 |
5 | Biophysics | 553 | 7% | 0% | 155 |
6 | Medicine, Research & Experimental | 286 | 5% | 0% | 124 |
7 | Virology | 175 | 3% | 0% | 61 |
8 | Cell Biology | 168 | 6% | 0% | 151 |
9 | Genetics & Heredity | 132 | 5% | 0% | 108 |
10 | Oncology | 100 | 6% | 0% | 132 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IG THER Y CO | 130308 | 0% | 100% | 10 |
2 | ABT BIOTECHNOL | 68165 | 1% | 35% | 15 |
3 | ANESTHESIA PHARMACEUT CHEM | 41681 | 1% | 27% | 12 |
4 | RECOMBINANT ANTIBODIES | 40717 | 0% | 63% | 5 |
5 | BIOTECHNOL ANTICORPS | 36079 | 0% | 46% | 6 |
6 | RECOMBINANT ANTIBODY GRP 0445 | 26062 | 0% | 100% | 2 |
7 | TUMOR IMMUNOL PROGRAMME MOL IMMUNOL 0740 | 26062 | 0% | 100% | 2 |
8 | WYETH IRELAND | 26062 | 0% | 100% | 2 |
9 | AD T CLUSTER | 23453 | 0% | 60% | 3 |
10 | SHANGHAI ADV IMMUNOL STUDIES | 23453 | 0% | 60% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PORTLAND PRESS PROCEEDINGS | 138952 | 1% | 33% | 32 |
2 | JOURNAL OF IMMUNOLOGICAL METHODS | 58939 | 9% | 2% | 209 |
3 | PROTEIN ENGINEERING DESIGN & SELECTION | 27642 | 2% | 5% | 47 |
4 | MABS | 19218 | 1% | 4% | 33 |
5 | PROTEIN ENGINEERING | 13208 | 2% | 2% | 48 |
6 | HYBRIDOMA AND HYBRIDOMICS | 8964 | 1% | 5% | 13 |
7 | JOURNAL OF MOLECULAR BIOLOGY | 7380 | 5% | 1% | 116 |
8 | BIO-TECHNOLOGY | 5642 | 1% | 2% | 25 |
9 | BMC BIOTECHNOLOGY | 3567 | 1% | 2% | 18 |
10 | BIOTECHNIQUES | 3547 | 2% | 1% | 41 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | 1035658 | 20% | 17% | 461 | Search PHAGE+DISPLAY | Search PHAGE+DISPLAY |
2 | SCFV | 818801 | 9% | 30% | 212 | Search SCFV | Search SCFV |
3 | ANTIBODY LIBRARY | 627160 | 3% | 63% | 76 | Search ANTIBODY+LIBRARY | Search ANTIBODY+LIBRARY |
4 | SINGLE CHAIN FV | 552425 | 5% | 40% | 107 | Search SINGLE+CHAIN+FV | Search SINGLE+CHAIN+FV |
5 | ANTIBODY ENGINEERING | 468366 | 6% | 28% | 130 | Search ANTIBODY+ENGINEERING | Search ANTIBODY+ENGINEERING |
6 | INTRABODY | 446438 | 3% | 49% | 70 | Search INTRABODY | Search INTRABODY |
7 | RECOMBINANT ANTIBODY | 233380 | 4% | 20% | 89 | Search RECOMBINANT+ANTIBODY | Search RECOMBINANT+ANTIBODY |
8 | PHAGE ANTIBODY | 226214 | 1% | 69% | 25 | Search PHAGE+ANTIBODY | Search PHAGE+ANTIBODY |
9 | INTRACELLULAR ANTIBODIES | 192436 | 1% | 62% | 24 | Search INTRACELLULAR+ANTIBODIES | Search INTRACELLULAR+ANTIBODIES |
10 | SINGLE CHAIN ANTIBODY | 169471 | 3% | 21% | 63 | Search SINGLE+CHAIN+ANTIBODY | Search SINGLE+CHAIN+ANTIBODY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOOGENBOOM, HR , (2005) SELECTING AND SCREENING RECOMBINANT ANTIBODY LIBRARIES.NATURE BIOTECHNOLOGY. VOL. 23. ISSUE 9. P. 1105-1116 | 91 | 58% | 502 |
2 | BRADBURY, ARM , MARKS, JD , (2004) ANTIBODIES FROM PHAGE ANTIBODY LIBRARIES.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 290. ISSUE 1-2. P. 29-49 | 94 | 69% | 162 |
3 | AHMAD, ZA , YEAP, SK , ALI, AM , HO, WY , ALITHEEN, NBM , HAMID, M , (2012) SCFV ANTIBODY: PRINCIPLES AND CLINICAL APPLICATION.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - | 86 | 58% | 62 |
4 | JARA-ACEVEDO, R , DIEZ, P , GONZALEZ-GONZALEZ, M , DEGANO, RM , IBARROLA, N , GONGORA, R , ORFAO, A , FUENTES, M , (2016) METHODS FOR SELECTING PHAGE DISPLAY ANTIBODY LIBRARIES.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 43. P. 6490 -6499 | 67 | 74% | 1 |
5 | HOOGENBOOM, HR , DE BRUINE, AP , HUFTON, SE , HOET, RM , ARENDS, JW , ROOVERS, RC , (1998) ANTIBODY PHAGE DISPLAY TECHNOLOGY AND ITS APPLICATIONS.IMMUNOTECHNOLOGY. VOL. 4. ISSUE 1. P. 1 -20 | 88 | 65% | 306 |
6 | MIERSCH, S , SIDHU, SS , (2012) SYNTHETIC ANTIBODIES: CONCEPTS, POTENTIAL AND PRACTICAL CONSIDERATIONS.METHODS. VOL. 57. ISSUE 4. P. 486-498 | 91 | 49% | 36 |
7 | ZHAO, AZ , TOHIDKIA, MR , SIEGEL, DL , COUKOS, G , OMIDI, Y , (2016) PHAGE ANTIBODY DISPLAY LIBRARIES: A POWERFUL ANTIBODY DISCOVERY PLATFORM FOR IMMUNOTHERAPY.CRITICAL REVIEWS IN BIOTECHNOLOGY. VOL. 36. ISSUE 2. P. 276 -289 | 48 | 68% | 5 |
8 | BRADBURY, ARM , SIDHU, S , DUBEL, S , MCCAFFERTY, J , (2011) BEYOND NATURAL ANTIBODIES: THE POWER OF IN VITRO DISPLAY TECHNOLOGIES.NATURE BIOTECHNOLOGY. VOL. 29. ISSUE 3. P. 245-254 | 73 | 44% | 162 |
9 | DE HAARD, H , HENDERIKX, P , HOOGENBOOM, HR , (1998) CREATING AND ENGINEERING HUMAN ANTIBODIES FOR IMMUNOTHERAPY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 31. ISSUE 1-2. P. 5 -31 | 107 | 60% | 23 |
10 | INBAR, NH , BENHAR, I , (2012) SELECTION OF ANTIBODIES FROM SYNTHETIC ANTIBODY LIBRARIES.ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. VOL. 526. ISSUE 2. P. 87 -98 | 70 | 58% | 9 |
Classes with closest relation at Level 1 |